Philip Vance, DMD
Oral and Maxillofacial Surgery · Temple, TXNPI 1750346656
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $549 of the $678 with a category attached, or 81.0%. 7 manufacturers reported payments, led by Acumed LLC at 46.2% of the total. 2025 is the largest year on record at $368, 5.5 times the $67 reported in 2019. That places this record below the midpoint for oral and maxillofacial surgery clinicians in TX, where the typical reported total is $924.
Across 15 payments — averaging $45.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acumed LLC$313
- Osteomed LLC$129
- Medical Device Business Services, Inc.$119
- Axogen$40
- Zimmer Biomet$26
- Stryker$26
- plus $24 from 1 others
What the payments were for
- Food & beverage$54981%
- Education$12919%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acumed LLC | 6 | $313 |
| Osteomed LLC | 2 | $129 |
| Medical Device Business Services, Inc. | 3 | $119 |
| Axogen | 1 | $40 |
| Zimmer Biomet | 1 | $26 |
| Stryker | 1 | $26 |
| Pylant Medical | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OsteoMed$121
How this compares
$678 in reported general payments places this provider in the 40th percentile of 591 oral and maxillofacial surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 26 | $1,157 |
| Naloxone Hcl | 11 | $632 |
| Chlorhexidine Gluconate | 132 | $592 |
| Pentoxifylline | 23 | $586 |
| Methocarbamol | 25 | $506 |
| Clindamycin Hcl | 12 | $276 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $249 |
| Tramadol Hcl | 34 | $164 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $156 |
| Ondansetron Hcl | 49 | $114 |
| Lidocaine Hcl ViscousLidocaine Hcl | 11 | $111 |
| Amoxicillin | 30 | $99 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 14 | $60 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Temple
- James MelvilleHouston$239K
- Pedro FrancoIrving$91K
- Fayette WilliamsFort Worth$74K
- Craig BuchmannKeller$69K
- John ZunigaDallas$61K
- David AlfiHouston$58K
- Herman KaoFort Worth$41K
- John ShroyerArlington$41K
- Craig PearlHouston$38K
- Edward EllisSan Antonio$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.